Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,000 | 1 | 93.9% |
| Food and Beverage | $65.41 | 3 | 6.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,000 | 1 | $0 (2023) |
| Lilly USA, LLC | $65.41 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,000 | 1 | PFIZER INC. ($1,000) |
| 2018 | $52.20 | 2 | Lilly USA, LLC ($52.20) |
| 2017 | $13.21 | 1 | Lilly USA, LLC ($13.21) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/07/2023 | PFIZER INC. | NURTEC ODT (Drug) | — | Cash or cash equivalent | $1,000.00 | Research |
| Study: PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE • Category: PAIN | ||||||
| 11/15/2018 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $41.08 | General |
| Category: Neuroscience | ||||||
| 07/17/2018 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $11.12 | General |
| 09/22/2017 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE | PFIZER INC. | $1,000 | 1 |
About Dr. Christopher Jackman, MD
Dr. Christopher Jackman, MD is a Specialist healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609081264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Jackman, MD has received a total of $1,065 in payments from pharmaceutical and medical device companies, with $1,000 received in 2023. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "" ($1,000).
Practice Information
- Specialty Specialist
- Other Specialties Neurology, Neurology with Special Qualifications in Child Neurology
- Location Indianapolis, IN
- Active Since 05/14/2007
- Last Updated 03/11/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1609081264
Products in Payments
- NURTEC ODT (Drug) $1,000
- EMGALITY (Drug) $41.08
- AMYVID (Drug) $13.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Indianapolis
Dr. Christopher Obeime, Md, MD
Specialist — Payments: $911,807
Dr. David Muram, Md, MD
Specialist — Payments: $570,000
Brian Mullis, Md, MD
Specialist — Payments: $547,817
Dr. Bruce Van Natta, Md, MD
Specialist — Payments: $425,360
Joachim Wernicke, Md, MD
Specialist — Payments: $412,683
Eromonsele Idahosa, Md, MD
Specialist — Payments: $122,569